Stifel raises FormFactor stock price target on strong margins By Investing.com

FormFactor reported Q1 2026 EPS of $0.56 and revenue of $226.1 million, beating expectations of $0.44 and $203.84 million, respectively, while gross margin expanded 510 bps to 49.0%. Stifel raised its price target to $135 from $75 on stronger results and outlook, though it kept a Hold rating due to a high valuation and near-term capacity constraints. Management said revenue, margin and earnings guidance all exceeded expectations, with the new Investor Day scheduled for May 11.

Analysis

The market is pricing FORM as if current margins are the new baseline, but the real question is whether this is a transition quarter or the start of a structurally higher earnings power regime. The near-term setup is still levered to timing: if the new facility ramp slips or customer qualification runs long, the multiple can compress quickly because the stock has already front-ran several years of execution. In other words, the equity is less about “can they grow” and more about “can they de-risk the path to the 2026-2027 model without a reset.”

Second-order winners are the ecosystem suppliers tied to accelerated test and advanced packaging demand, especially where FORM’s exposure signals broader AI/networking capex rather than one-off share gains. NVDA is the cleaner read-through: if networking remains the driver, this reinforces that AI infrastructure spend is still broadening beyond accelerators into optics, interconnect, and validation tools. INTC’s mention matters less as a revenue source than as a potential cyclical inflection in legacy test demand; if that recovery stalls, it weakens the argument that FORM’s outperformance is driven by a durable semi upcycle rather than a few large programs.

The contrarian risk is that consensus is extrapolating gross margin expansion into perpetuity while ignoring mix and capacity normalization. A 45x forward multiple only works if investors believe the company can compound above-target revenue with no margin giveback as the factory ramps; that is a high bar for a name already up sharply and trading well above fundamental anchors. If the Investor Day target model disappoints, the rerating could reverse over days, not months.

The better trade is not chasing the outright long after an earnings-led gap, but expressing a relative-value view. FORM has become a “good news required” name, while NVDA remains the higher-quality way to own the AI infrastructure cycle without single-factory execution risk. The asymmetry is now more attractive in short-dated downside protection than in fresh directional longs.

Key Decisions for Investors

• Avoid initiating new outright longs in FORM ahead of Investor Day; if already long, consider trimming 25-35% into strength and keep the residual for the May 11 catalyst.
• Buy FORM downside protection via 1-3 month puts or put spreads into the Investor Day window; structure for a post-event multiple reset if the refreshed target model fails to raise the growth trajectory meaningfully.
• Pair trade: long NVDA / short FORM for 1-3 months to express the view that broad AI infrastructure spending is better owned through the platform leader than a high-multiple tools name with facility-ramp risk.
• If FORM pulls back 10-15% without a deterioration in estimates, use that as a more attractive entry point; risk/reward improves only after the market stops paying up for flawless execution.